MTW9, a transplantable mammary tumor in Wistar Furth rats, shows little growth unless host serum prolactin is increased. This study compares the response to ovariectomy of MTW9-MtT, a tumor developed in rats bearing the mammosomatotropic tumor MtTW10 (serum prolactin 500 to 7000 ng/ml) with MTW9-P developed in rats given chronic perphenazine treatment (4 mg/kg/day). Serum prolactin concentrations were 150 to 600 ng/ml in MTW9-P-bearing rats. MTW9-MtT does not regress after ovariectomy but does regress after surgical removal (resection) of MtT. Ovariectomy plus MtT resection leads to greater tumor regression than MtT resection alone.

MTW9-P does not regress when perphenazine administration is stopped but does regress after ovariectomy, whether or not rats are given perphenazine. Administration of estradiol (10 μg/day) to rats with complete ovariectomy-induced regression of MTW9-P results in regrowth of tumor.

These data suggest that MTW9-P may represent a clone of MTW9 with a lower requirement for prolactin.


This investigation was supported by USPHS Research Grants CA 5215, CA 10064, CA 14194, and CA 02332 from the National Cancer Institute.

This content is only available via PDF.